NeurologyLive® Friday 5 — December 12, 2025

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

Click the read more and watch now buttons for more details and information about each highlight.

1: FDA Action Update, November 2025: Approvals, Clearance, and Boxed Warning

In November 2025, the FDA was busy making a number of decisions on potential new therapeutic agents, including granting approvals and a clearance, issuing a complete response letter, adding a box warning, providing feedback, and reconsidering its stance on a submission.

2: Inside the 2026 MDA Conference: Keynote Insights and Evolving Neuromuscular Care

Sharon Hesterlee, PhD, president and CEO of the Muscular Dystrophy Association (MDA), recently discussed the 2026 MDA Conference, the significance of its keynote speaker, and the evolving therapeutic landscape in neuromuscular medicine.

3: How Public and Media-Driven Misconceptions of Narcolepsy Could Impact Diagnosis: Julie Flygare, JD

In a recent interview, Julie Flygare, JD, the president and CEO at Project Sleep, discussed how inaccurate media portrayals of narcolepsy can contribute to stigma, misunderstanding of symptoms, and delays in clinical diagnosis. [WATCH TIME: 5 minutes]

4: NeuroVoices: Richard Rammo, MD, on How Thalamic Neuromodulation is Evolving for Drug Resistant Epilepsy

In our latest NeuroVoices, Richard Rammo, MD, neurosurgeon at Cleveland Clinic discussed the goals of the AES thalamic neuromodulation special interest group and the major clinical and research priorities shaping the future of neuromodulation for drug resistant epilepsy.

5: Issues Surrounding Reproductive Health in Women with Epilepsy: Esther Bui, MD

At AES 2025, Esther Bui, MD, a clinician educator at the University of Toronto, discussed the complex challenge of caring for women with epilepsy that demands both clinical expertise and personalized care. [WATCH TIME: 4 minutes]